EMA Information Session on Biosimilars for Patients and Healthcare Professionals

5 March 2015

Video

What you Need to Know About Biosimilar Medicinal Products

22 February 2015

External Resource

French Parliament Public Hearing on Biosimilar Medicines, Paris, 29 January 2015 – Intervention from EMA Spokesperson Camille Vleminckx

29 January 2015

Policy

Labelling & Naming – EBG Perspective, DIA Berlin 2014

3 December 2014

Policy

WHO BQ Proposal – EGA’s perspective, 59th INN Consultation, WHO, Geneva, 14 October 2014

14 October 2014

Policy

GfK – Factors Supporting a Sustainable European Biosimilar Medicines Market

9 September 2014

Report

A study about the future sustainability of the biosimilar medicines […]

EMA mAb Workshop – Guideline on Similar Biological Medicinal Products

31 October 2013

Policy, Video

EMA mAb Workshop – Quality Target Product Profile in the Development of a Biosimilar

31 October 2013

Policy, Video

EMA mAb Workshop – Stepwise Approach to Non-Clinical Program

31 October 2013

Policy, Video

International Generic Pharmaceutical Alliance (IGPA) Letter Regarding TGA Guidance Titled “Evaluation of Biosimilars”, 2013

18 September 2013

Policy